menu close

2nd February 2022

pharmasol completes merger with PharmaLex Group

Strategic consolidation brings pharmasol’s industry-leading SUSAR distribution platform plus full-service pharmacovigilance business support capabilities to expanded Group

Kaiserslautern, Germany, February 2nd 2022 – pharmasol, a leading provider of specialist software and full-service solutions to optimise business-critical pharmacovigilance processes, today announces that it has completed a merger with PharmaLex – one of the world’s largest providers of specialised services for the pharma, biotech and medtech industries.

pharmasol brings key pharmacovigilance and end-to-end business support expertise to the expanded Group, extending the solution footprint of PharmaLex’s established Technology-Enabled Smart Services (TESS) division. With more than 20 years’ heritage in successfully serving the life sciences industry, pharmasol enables organisations to effectively implement, automate and optimise regulatory responsibilities, including SUSAR (Suspected Unexpected Serious Adverse Reactions) distribution via its industry-leading psiXchange platform. psiXchange is the only software developed exclusively for the business-critical process of automated safety letter distribution, today delivering state-of-the-art distribution capabilities to a diverse customer base spanning leading pharmaceutical and biotech companies and top 10 global CROs.

pharmasol’s full-service portfolio includes innovative applications, specialist consultancy, GxP compliant hosting and gold-standard implementation services – including rapidLIVE, an accelerated, pre-packaged and high ROI implementation solution for Oracle Argus Safety. 

“This strategic partnership with PharmaLex is a key milestone in our mission to create a dominant market position and enhance our total solution portfolio offering to our clients,” said pharmasol CEO Torsten Adam. “This landmark alliance empowers both organisations to offer greater depth and breadth of service in the fast-growing and highly competitive area of pharmacovigilance – from best-in-class IT solutions, hosting and business process automation to strategic consultancy services.”

“We are delighted to have completed this strategic merger with pharmasol, and to be enhancing our solution set with pharmasol’s proven, specialist solutions that support companies to cost-effectively and efficiently meet their regulatory and operational responsibilities while increasing compliance,” said PharmaLex CEO Dr. Thomas Dobmeyer. “With this consolidation of expertise from two industry leaders, we are excited to be further expanding our capabilities, and providing customers with access to pharmasol’s unparalleled technical expertise, highly talented team, and scalable, next-generation technology that will be instrumental in helping the industry to meet the complex data strategy and governance challenges, now and in the future.”

—Ends—

About PharmaLex

PharmaLex is a leading provider of specialized services for the pharma, biotech and medtech industries. We guide you from early strategic planning activities and non-clinical requirements through clinical development, regulatory submission processes and post-approval / maintenance post-launch activities. Our experts use technology-enabled solutions to support you through the entire product lifecycle. We deliver exceptional results — going above and beyond the standard to deliver tailor-made solutions worldwide.

The PharmaLex Group now has over 1,700 employees, with 45 offices in 24 countries and more than 1,000 satisfied clients worldwide.

About pharmasol (https://pharmasol.de/)

pharmasol is a leading provider of specialist software and full-service solutions that optimise business-critical pharmacovigilance processes for the life sciences industry. pharmasol’s full-service portfolio includes innovative software applications, specialist sector consultancy, GxP compliant hosting and gold-standard implementation services, including Argus rapidLIVE, to help companies efficiently meet their regulatory and operational responsibilities – substantially reducing costs, boosting efficiency and increasing compliance for pharmaceutical, biotech and Clinical Research Organisations worldwide.

With more than 20 years’ heritage in delivering industry-leading solutions to life sciences organisations of all sizes, pharmasol enables organisations to effectively implement, automate and optimise key regulatory responsibilities across the entire pharmacovigilance function – including SUSAR document distribution via its industry-leading psiXchange platform.

For further information about pharmasol, please visit: www.pharmasol.de

psiXchange is the only software developed exclusively for the business-critical process of automated safety letter distribution, today delivering state-of-the-art capabilities to customers spanning leading pharmaceutical and biotech companies and top 10 global CROs. psiXchange provides a fully automated, best-in-class solution that streamlines complex, multi-site distribution processes for SUSARs, training materials and other critical safety documents – providing full tracking and audit capabilities and delivering improved compliance, greater oversight and significant cost savings. Global offices for pharmasol are located in Germany, the UK and the U.S.

PRESS CONTACT for Pharmasol:
Nicky Denovan
EvokedSet PR
Email: nicky[at]evokedset[dot]com
Phone: +44 (0) 118 328 2782

PRESS CONTACT for PharmaLex
Ms. Elizabeth Hunt
Manager External Communications
Email: elizabeth.hunt[at]pharmalex[dot]com
Phone: +00 353 86 811 2319

News and events

New rapidLIVE infographic

21st June 2024

Find out more chevron_right

Download our new rapidLIVE brochure

26th April 2024

Find out more chevron_right

NEW: psiXchange brochure and infographic

6th March 2024

Find out more chevron_right

On-demand Webinar Recording: Improving Safety Reporting Speed and Accuracy with Automation and Embedded Intelligence

22nd February 2024

Find out more chevron_right

PharmaLex Talks podcast - Scaling Patient Safety through Innovation

25th September 2023

Find out more chevron_right

PharmaLex Talks podcast - Safety Reporting Requirements for Marketing in the EU

6th July 2023

Find out more chevron_right

The Quest For Quality: Ensuring Good Clinical Practice in Clinical Trials

31st January 2023

Find out more chevron_right

Upcoming Event: pharmasol at PIPA Conference 2022

14th September 2022

Find out more chevron_right

Upcoming Event: World Drug Safety Europe 2022

14th September 2022

Find out more chevron_right

WEBINAR: rapidLIVE and Oracle Argus – fast-track to the gold standard PV database for life science SMEs

17th May 2022

Find out more chevron_right

RapidLIVE transforms case processing efficiency for award-winning PV service provider IntuVigilance

8th April 2022

Find out more chevron_right

Juggling the regulatory complexities of global clinical trials (pharmamanufacturing.com)

23rd February 2022

Find out more chevron_right

pharmasol completes merger with PharmaLex Group

2nd February 2022

Find out more chevron_right

Automating safety processes can benefit DCTs: Pharmasol (outsourcing-pharma.com)

1st December 2021

Find out more chevron_right

pharmasol Launches New psiXchange Capabilities to Enhance Delivery of Clinical Trial Safety Documentation

1st June 2021

Find out more chevron_right

From Signature to Go-live in 6 weeks

10th July 2020

Find out more chevron_right

pharmasol Achieves ISO 27001 Certification

21st April 2020

Find out more chevron_right

Using Third Parties in Business Continuity Plans

6th April 2020

Find out more chevron_right

Business as Usual (at This Unusual Time)

19th March 2020

Find out more chevron_right

Oracle introduced Flexible Code Lists as part of the Argus 8 release

5th February 2020

Find out more chevron_right

New whitepaper – Iterative implementation approach

20th September 2019

Find out more chevron_right

Clarification regarding “Pharmasol Corporation”

1st July 2019

Find out more chevron_right

What’s the most powerful phrase in System Implementation? Why?

22nd May 2019

Find out more chevron_right

Another hosted Argus customer live in record time

8th February 2019

Find out more chevron_right

Right-sizing for Safety Database Implementation

18th January 2019

Find out more chevron_right

How psiXchange and CTM can make your safety reporting life easier!

7th December 2018

Find out more chevron_right

12 months of success for the Argus team

22nd May 2018

Find out more chevron_right

How automation is uncovering hidden insights

30th April 2018

Find out more chevron_right

Coding Of Clinical Data In A World After dsNavigator

18th April 2018

Find out more chevron_right

Release update – March 2018 – Important information for existing customers.

8th March 2018

Find out more chevron_right

What’s a smart portal?

29th January 2018

Find out more chevron_right

APEX success

27th October 2017

Find out more chevron_right

New Strategic psiXchange Deployment with Leading CRO

16th November 2016

Find out more chevron_right

pharmasol Launches Update to Business Process Automation System

16th February 2016

Find out more chevron_right

Investigators’ Experience With Expedited Safety Reports

10th September 2014

Find out more chevron_right